Psychemedics (PMD) Reports Q1 EPS of $0.11 on Revenues of $9.8M
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/2/2026
- Equities close higher as softer jobs data quiets rate-hike expectations
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- DataMeds AI's Corexa Pharmacy tops $1M in monthly revenue
- Equities rebound to close higher as surging Treasury yields recede
- onsemi cuts Synaptics deal price to $5.7B after rival bid
- Wells Fargo names 13 stocks as overweight tactical ideas
- Cantor Fitzgerald on Rivian (RIVN): 'pre-announced that it delivered 19,248 vehicles in 3Q26, above our estimate'
Psychemedics Announces First Quarter Results and Declares 91st Consecutive Quarterly Dividend
April 23, 2019 5:25 PM EDTACTON, Mass., April 23, 2019 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD) today announced first quarter financial results for the period ended March 31, 2019. The Company also announced a quarterly dividend of $0.18 per share payable to shareholders of record as of May 7, 2019, to be paid on May 17, 2019. This will be the Companys 91st consecutive quarterly dividend.
The Companys revenue for the quarter ended March 31, 2019 was $9.8 million versus $10.9 million for the quarter ended March 31, 2018, a decrease of 10%. Net income for the quarter ended March 31, 2019 was $0.6 million or $0.11 per diluted share, versus $1.3... More
